Clinical Trial Update: Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating glycopyrrolate for moderate-to-severe sialorrhea in Parkinson's disease; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Sialorrhea, Parkinson's Disease | Phase 2 | Status: UNKNOWN